States sue 20 generic drug companies and 15 executives for allegedly conspiring to fix prices for more than 100 drugs
May 14, 2019
A 44-state coalition of attorneys general is suing Teva Pharmaceuticals and 19 of the nation's largest generic drug manufacturers alleging a conspiracy to increase prices and reduce competition for more than 100 generic drugs.
The lawsuit, filed in federal court, also names 15 individual senior executive defendants, leaders of the conspiracy, who were responsible for sales, marketing, pricing, and operations. The drugs make up billions of dollars of sales in the United States, and the alleged schemes increased prices affecting the health insurance market, taxpayer-funded healthcare programs such as Medicare and Medicaid, and individuals who had to pay artificially-inflated prices for their prescriptions drugs.
All types of drugs were included – tablets, capsules, suspensions, creams, gels, and ointments – as well as many classes of drugs – statins, ace inhibitors, beta blockers, antibiotics, anti-depressants, contraceptives, and non-steroidal anti-inflammatory drugs. The drugs treat a range of diseases and conditions from basic infections to diabetes, cancer, epilepsy, multiple sclerosis, HIV, ADHD, and more. In some cases, the coordinated price increases were more than 1,000 percent.
The lawsuit lays out an interconnected web of industry executives where these competitors met during industry dinners, "girls nights out," lunches, cocktail parties, and golf outings, and communicated by telephone calls, emails, and text messages that laid the groundwork for their illegal agreements. The lawsuit said defendants used terms such as "fair share," "playing nice in the sandbox," and "responsible competitor" to describe how they unlawfully discouraged competition, raised prices, and enforced a culture of collusion.
The lawsuit seeks damages, penalties, and actions by the court to restore competition to the generic drug market.
"We have hard evidence that shows the generic drug industry perpetrated a multi-billion-dollar fraud on the American people,” said Connecticut Attorney General William Tong. “We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs.”
The drugs included in the lawsuit are ones that people rely on every day for acute and chronic conditions and diseases ranging from diabetes and cancer to depression and arthritis, said Tong.
“We all wonder why our healthcare, and specifically the prices for generic prescription drugs, are so expensive in this country – this is a big reason why,” he said. “This investigation is still in its early stages. We will not stop until these companies and the individuals who orchestrated these schemes are held accountable.”
The lawsuit is the second to be filed in an ongoing investigation that the Connecticut Attorney General’s Office has referred to as possibly the largest cartel case in the U.S. history.
The first lawsuit, pending in federal court, was filed in 2016 and now includes 18 corporate defendants, two individual defendants, and 15 generic drugs. Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have entered into settlement agreements and are cooperating with the attorneys general working group in that case, Tong said.
In addition to Connecticut, Alabama, Alaska, Arizona, Colorado, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Puerto Rico joined the lawsuit.
Corporate defendants
- Teva Pharmaceuticals USA Inc.
- Sandoz Inc.
- Mylan Pharmaceuticals Inc.
- Actavis Holdco US Inc.
- Actavis Pharma Inc.
- Amneal Pharmaceuticals Inc.
- Apotex Corp.
- Aurobindo Pharma U.S.A. Inc.
- Breckenridge Pharmaceutical Inc.
- Reddy’s Laboratories Inc.
- Glenmark Pharmaceuticals Inc. USA
- Greenstone LLC
- Lannett Company Inc.
- Lupin Pharmaceuticals Inc.
- Par Pharmaceutical Companies Inc.
- Pfizer Inc.
- Taro Pharmaceuticals USA Inc.
- Upsher-Smith Laboratories LLC
- Wockhardt USA LLC
- Zydus Pharmaceuticals (USA) Inc.
Individual defendants
- Ara Aprahamian, vice president of sales and marketing at Taro Pharmaceuticals U.S.A. Inc.
- David Berthold, vice president of sales at Lupin Pharmaceuticals Inc.
- James Brown, vice president of sales at Glenmark Pharmaceuticals Inc.
- Maureen Cavanaugh, former senior vice president and chief commercial officer, North America, for Teva
- Marc Falkin, former vice president, marketing, pricing, and contracts at Actavis
- James Grauso, former senior vice president, commercial operations for Aurobindo from December 2011 through January 2014. Since February 2014, Grauso has been employed as the executive vice president, N.A. commercial operations at Glenmark
- Kevin Green, former director of national accounts at Teva from January 2006 through October 2013. Since November 2013, Green has worked at Zydus Pharmaceuticals (USA) Inc. as the vice president of sales
- Armando Kellum, former vice president, contracting and business analytics at Sandoz
- Jill Nailor, senior director of sales and national accounts at Greenstone
- James Nesta, vice president of sales at Mylan
- Kon Ostaficiuk, the president of Camber Pharmaceuticals Inc.
- Nisha Patel, former director of strategic customer marketing, and later, director of national accounts at Teva.
- David Rekenthaler, former vice president, sales US generics at Teva
- Richard Rogerson, former executive director of pricing and business analytics at Actavis
- Tracy Sullivan DiValerio, director of national accounts at Lannett
Drugs listed in the lawsuit as being included in price-fixing and market allocation agreements:
- Adapalene Gel
- Amiloride HCL/HCTZ Tablets
- Amoxicillin/Clavulanate Chewable Tablets
- Amphetamine/Dextroamphetamine ER (aka Mixed Amphetamine Salts)
- Amphetamine/Dextroamphetamine IR
- Azithromycin Oral Suspension
- Azithromycin Suspension
- Baclofen Tablets
- Benazepril HCTZ
- Bethanechol Chloride Tablets
- Budesonide DR Capsules
- Budesonide Inhalation
- Bumetanide Tablets
- Buspirone Hydrochloride Tablets
- Cabergoline
- Capecitabine
- Carbamazepine Chewable Tablets
- Carbamazepine Tablets
- Cefdinir Capsules
- Cefdinir Oral Suspension
- Cefprozil Tablets
- Celecoxib
- Cephalexin Suspension
- Cimetidine Tablets
- Ciprofloxacin Tablets
- Clarithromycin ER Tablets
- Clemastine Fumarate Tablets
- Clomipramine HCL
- Clonidine TTS Patch
- Clotrimazole Topical Solution
- Cyproheptadine HCL Tablets
- Desmopressin Acetate Tablets
- Desogestrel/Ethinyl Estradiol Tablets (Kariva)
- Dexmethylphenidate
- Dextroamphetamine Sulfate ER
- Diclofenac Potassium Tablets
- Dicloxacillin Sodium Capsules
- Diflunisal Tablets
- Diltiazem HCL Tablets
- Disopyramide Phosphate Capsules
- Doxazosin Mesylate Tablets
- Drospirenone and ethinyl estradiol (Ocella)
- Enalapril Maleate Tablets
- Entecavir
- Epitol Tablets
- Estazolam Tablets
- Estradiol Tablets
- Ethinyl estradiol and levonorgestrel (Portia and Jolessa)
- Ethosuximide Capsules
- Ethosuximide Oral Solution
- Etodolac ER Tablets
- Etodolac Tablets
- Fenofibrate
- Fluconazole Tablets
- Fluocinonide Cream
- Fluocinonide Emolient Cream
- Fluocinonide Gel
- Fluocinonide Ointment
- Fluoxetine HCL Tablets
- Flurbiprofen Tablets
- Flutamide Capsules
- Fluvastatin Sodium Capsules
- Gabapentin Tablets
- Glimepiride Tablets
- Griseofulvin Suspension
- Haloperidol
- Hydroxyurea Capsules
- Hydroxyzine Pamoate Capsules
- Irbesartan
- Isoniazid
- Ketoconazole Cream
- Ketoconazole Tablets
- Ketoprofen Capsules
- Ketorolac Tromethamine Tablets
- Labetalol HCL Tablets
- Lamivudine/Zidovudine (generic Combivir)
- Levothyroxine
- Loperamide HCL Capsules
- Medroxyprogesterone Tablets
- Methotrexate Tablets
- Mimvey (Estradiol/Noreth) Tablets
- Moexipril HCL Tablets
- Moexipril HCL/HCTZ Tablets
- Nabumetone Tablets
- Nadolol Tablets
- Niacin ER Tablets
- Nitrofurantoin MAC Capsules
- Norethindrone/ethinyl estradiol (Balziva)
- Northindrone Acetate
- Nortriptylline Hydrochloride Capsules
- Omega-3-Acid Ethyl Esters
- Oxaprozin Tablets
- Oxybutynin Chloride Tablets
- Paricalcitol
- Penicillin VK Tablets
- Pentoxifylline Tablets
- Piroxicam
- Pravastatin Sodium Tablets
- Prazosin HCL Capsules
- Prochlorperazine Tablets
- Propranolol HCL Tablets
- Raloxifine HCL Tablets
- Ranitidine HCL Tablets
- Tamoxifen Citrate Tablets
- Temozolomide
- Tizanidine
- Tobramycin
- Tolmetin Sodium Capsules
- Tolterodine ER
- Tolterodine Tartrate
- Topiramate Sprinkle Capsules
- Trifluoperazine HCL
- Valsartan HCTZ
- Warfarin Sodium Tablets
Comments
You can follow this conversation by subscribing to the comment feed for this post.